Skip to content
AcquiredAcquired

Novo Nordisk (Ozempic)

Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about Novo Nordisk before diving in, our first thought was, “wow, seems like these new diabetes and obesity drugs mean serious trouble for big insulin companies.” And then… we realized that Novo Nordisk IS the big insulin company. And in a story befitting of Steve Jobs and Apple, they’d just disrupted themselves with the drug equivalent of an iPhone moment. Once we dug further, we quickly realized this company has it all: an incredible 100+ year history filled with Nobel Prizes, bitter personal rivalries, board room dramas, a generation-defining silicon valley innovation, lone voices persevering against all odds — and oh yeah, the world’s largest charitable foundation at its helm. Tune in for one incredible story! *Links:* - Chart: US Healthcare Spend by Category: https://www.drugchannels.net/2022/02/still-not-skyrocketing-new-cms-data.html - Chart: US Distribution and Reimbursement System (for pharmaceutical drugs): https://www.drugchannels.net/2019/03/new-2019-economic-report-on-us.html - Chart: Insulin Supply Chain: https://diabetesjournals.org/view-large/figure/3430167/dci180019f3.jpeg - YouTube Talk: What People Get Wrong about the Finances of the Drug Industry: https://www.youtube.com/watch?v=3LGqQJFdoWM - Alex Telford: The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it: https://atelfo.github.io/2023/12/23/biopharma-from-janssen-to-today.html - Out-of-Pocket Health: Obesity Drugs: https://www.outofpocket.health/p/lets-talk-about-obesity-drugs?fromEmail=true - Out-of-Pocket Health: US Healthcare System Problems: https://www.outofpocket.health/p/all-of-the-main-problems-with-us-healthcare - All episode sources: https://www.acquired.fm/episodes/novo-nordisk-ozempic#sources *Carve Outs:* - Noxgear Tracer 2 running vest: https://www.noxgear.com/tracer2 - Drops of God: https://www.imdb.com/title/tt15282746/ - Wool by Hugh Howey: https://www.amazon.com/Wool-Hugh-Howey/dp/1476733953 - Mere Mortals at San Francisco Ballet: https://www.sfballet.org/productions/mere-mortals/ - Blackberry: https://www.imdb.com/title/tt21867434/ _Note: Acquired hosts and guests may hold assets discussed in this episode. This podcast is not investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions._

Ben GilberthostDavid Rosenthalhost
Jan 22, 20243h 45mWatch on YouTube ↗

Episode Details

EPISODE INFO

Released
January 22, 2024
Duration
3h 45m
Channel
Acquired
Watch on YouTube
▶ Open ↗

EPISODE DESCRIPTION

Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much about Novo Nordisk before diving in, our first thought was, “wow, seems like these new diabetes and obesity drugs mean serious trouble for big insulin companies.” And then… we realized that Novo Nordisk IS the big insulin company. And in a story befitting of Steve Jobs and Apple, they’d just disrupted themselves with the drug equivalent of an iPhone moment. Once we dug further, we quickly realized this company has it all: an incredible 100+ year history filled with Nobel Prizes, bitter personal rivalries, board room dramas, a generation-defining silicon valley innovation, lone voices persevering against all odds — and oh yeah, the world’s largest charitable foundation at its helm. Tune in for one incredible story! *Links:*

*Carve Outs:*

_Note: Acquired hosts and guests may hold assets discussed in this episode. This podcast is not investment advice, and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any financial transactions._

SPEAKERS

  • Ben Gilbert

    host
  • David Rosenthal

    host

EPISODE SUMMARY

In this episode of Acquired, featuring Ben Gilbert and David Rosenthal, Novo Nordisk (Ozempic) explores novo Nordisk’s century journey from insulin to Ozempic dominance The episode traces Novo Nordisk from insulin’s 1920s origins through a decades-long Danish rivalry (Nordisk vs. Novo) that accelerated innovation in insulin purification, duration, and delivery.

RELATED EPISODES

Formula 1: Fast cars, celebrities, and B2B software (Audio)

Formula 1: Fast cars, celebrities, and B2B software (Audio)

The NFL: How small-town teams became America's most valuable sports empire (Audio)

The NFL: How small-town teams became America's most valuable sports empire (Audio)

Coca-Cola: The Complete History & Strategy (Audio)

Coca-Cola: The Complete History & Strategy (Audio)

Trader Joe’s: Hawaiian shirts and counter positioning (Audio)

Trader Joe’s: Hawaiian shirts and counter positioning (Audio)

Google Part III: The AI Company. Google is amazingly well-positioned... will they win in AI? (Audio)

Google Part III: The AI Company. Google is amazingly well-positioned... will they win in AI? (Audio)

10 Years of Acquired (with Michael Lewis)

10 Years of Acquired (with Michael Lewis)

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.